Veritone, Inc. 2018 PERFORMANCE-BASED STOCK INCENTIVE PLAN AMENDED AND RESTATED CEO award agreementCeo Award Agreement • September 1st, 2020 • Veritone, Inc. • Services-computer processing & data preparation
This Amended and Restated CEO Award Agreement amends and restates the CEO Award Agreement between Veritone, Inc. (the “Corporation”) and Chad Steelberg (the “Participant”) evidencing the Performance Option Grant (the “Award”) granted to the Participant on May 6, 2018 under the Veritone, Inc. 2018 Performance-Based Stock Incentive Plan, which was adopted effective as of May 6, 2018 and amended effective as of August 27, 2020 (the “Plan”), effective as of August 27, 2020.
CellCyte Genetics Corporation CEO Award AgreementCeo Award Agreement • June 5th, 2007 • Cellcyte Genetics Corp • Pharmaceutical preparations • Washington
This CEO Award Agreement (the "Agreement") is entered into as of June 1, 2007 (the "Effective Date"), by and between CellCyte Genetics Corporation, a Nevada corporation (the "Company"), and Gary A. Reys (the "CEO"). The purpose of this Agreement is (1) to define the required staff, physical plant, equipment and financing required to execute the Company's business plan and (2) to specify the how incentive compensation payments (each an "Award") shall be calculated for the CEO's satisfactory implementation of the foregoing elements of the Company's Business Plan.
